F8 and hemophilia A: In this study, we aimed to develop novel DPPC-Fe3O4 nanoparticles carrying a liver-specific BDD-FVIII expression plasmid as a nonviral gene delivery system for hemophilia A treatment in an FVIII knockout mouse model.